Share on StockTwits

Lpath (NASDAQ:LPTN) CEO Scott R. Pancoast purchased 10,000 shares of the company’s stock in a transaction dated Monday, August 18th. The shares were purchased at an average price of $3.22 per share, with a total value of $32,200.00. Following the completion of the acquisition, the chief executive officer now directly owns 106,435 shares in the company, valued at approximately $342,721. The acquisition was disclosed in a document filed with the SEC, which is available at this link.

Shares of Lpath (NASDAQ:LPTN) opened at 3.06 on Thursday. Lpath has a 52 week low of $2.75 and a 52 week high of $6.46. The stock’s 50-day moving average is $3.63 and its 200-day moving average is $4.16. The company’s market cap is $47.8 million.

Separately, analysts at MLV & Co
cut their price target on shares of Lpath from $13.00 to $11.00 in a research note on Wednesday, June 11th. They now have a “buy” rating on the stock.

Lpath, Inc is a biotechnology company focused on the discovery and development of lipidomic-based therapeutics, an emerging field of medical science whereby bioactive lipids are targeted to treat human diseases.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.